Shanghai VKEY Biotechnologies Co.,Ltd.
Shanghai VKEY Biotechnologies Co.,Ltd.
Email Us

Industry News

03
Feb
High-Throughput & Anti-Interference & Accurate Quantification ------ A New Hybridoma Screening Solution Combining Three Effects
The Challenges and Breakthroughs in Hybridoma ScreeningIn monoclonal antibody development, hybridoma screening is a critical bottleneck. Traditional methods (like ELISA) are time-consuming (often requ...
02
Feb
Comprehensive Analysis of TNFα and IL-6 Cytokine Detection Technologies
Introduction In the fields of immunology and inflammatory disease research, cytokines play a pivotal role. Among them, TNFα and IL-6, as two core inflammatory markers, are not only involved in regul...
01
Feb
cAMP Detection 'Three Musketeers': Classic, Wide-Range, and Ultra-Wide Detection—There’s One for Every Need
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger involved in regulating various physiological processes, such as metabolism, secretion, and gene expression. In drug de...
05
Apr
AACR 2024: Exploring New Breakthroughs in KRAS Inhibitors
As medical research progresses, remarkable strides continue to be made in cancer treatment. The American Association for Cancer Research (AACR) Annual Meeting, a globally renowned event, has long been...
07
Mar
Regarding GPCR Drug Development and Solutions
G-Protein Coupled Receptors (GPCRs) are one of the largest protein families in the human genome, widely distributed in central nervous system, immune system, cardiovascular system, and retina. As key ...